Medtronic (MDT) reported fiscal Q3 non-GAAP earnings Tuesday of $1.39 per diluted share, up from $1.30 a year earlier.
Analysts polled by FactSet expected $1.36.
Revenue for the fiscal quarter ended Jan. 24 was $8.29 billion, up from $8.09 billion a year earlier. Analysts surveyed by FactSet expected $8.33 billion.
For fiscal 2025, the medical devices and technology company maintained its previous non-GAAP EPS guidance of $5.44 to $5.50. Analysts polled by FactSet expect $5.45.
Medtronic also maintained its previous fiscal 2025 revenue growth forecast of 4.75% to 5%. Analysts surveyed by FactSet expect sales of $33.57 billion.
Shares were down nearly 1% in premarket activity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。